
Loading, please wait...

Loading, please wait...

Wearable sweat sensors represent a breakthrough in noninvasive, real-time biochemical monitoring for personalized healthcare. Researchers recently developed a wireless Janus paper-based microfluidic patch (JPMP) to overcome traditional limitations in liquid-holding capacity. This innovative system enables the continuous detection of glucose, creatinine, and uric acid in human sweat. By utilizing wax-printed Janus papers, the device achieves efficient unidirectional transport of biofluids even when saturated. Consequently, this technology offers a scalable and cost-effective solution for long-term metabolic health tracking.
The Janus paper-based microfluidic patch draws inspiration from natural mechanisms like the asymmetric wettability of lotus leaves. Furthermore, it incorporates leaf-tip-directed liquid transport to maintain sustained drainage. This design prevents sweat saturation from impeding the sensor's performance. The fabrication process uses a facile wax printing method, which ensures the scalable production of patterned Janus paper. Additionally, the device uses D-sorbitol-doped PEDOT:PSS conductive ink to create high-performance electrodes. These porous structures facilitate highly sensitive electrochemical detection of key metabolic analytes.
Ensuring the longevity of enzymatic sensors is crucial for reliable monitoring. Therefore, the researchers proposed an in-situ growth method for three-enzyme-inorganic hybrid nanoflowers on the electrodes. This technique significantly extends the operational lifespan of creatinine sensors. Moreover, during testing with healthy participants, the system successfully monitored postprandial metabolic changes. This validation demonstrates the device's potential to provide real-time data for managing conditions like diabetes and gout. Ultimately, these advancements pave the way for more accessible and proactive medical diagnostics in daily life.
These sensors use Janus paper to ensure a continuous one-way flow of fresh sweat to the electrodes. This mechanism prevents the mixing of old and new samples, which maintains data accuracy during prolonged wear.
While sweat glucose levels correlate with blood glucose, these sensors currently complement traditional testing. They provide continuous trends and noninvasive insights that help patients manage their metabolic health more effectively.
Standard paper-based devices often stop working once they become fully soaked. The Janus paper design uses asymmetric wettability to pump liquid away from the skin, allowing the sensor to function even under heavy perspiration.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zhang S et al. A wax-printed Janus paper-based microfluidic wearable sensor for metabolic analysis in sweat. Biosens Bioelectron. 2026 Jun 01. doi: undefined. PMID: 42224781.
Gao Y, Choi S. Micropatternable Janus Paper as a Wearable Skin Patch for Sweat Collection and Analysis. Adv Mater Technol. 2023. doi: 10.1002/admt.202300123.
Ye Z et al. Wearable Janus fabric SERS sensor for detection of urea, uric acid and pH in sweat. Sens Actuators B Chem. 2025. doi: 10.1016/j.snb.2024.138392.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Explore a wireless wearable system using Janus paper for real-time monitoring of glucose, creatinine, and uric acid in sweat for metabolic health....
4 months ago

A breakthrough peer-reviewed study demonstrates that a sequential AI diagnosis system can mirror real-world clinical reasoning. By ordering stepwise tests and updating hypotheses dynamically, this multi-agent orchestrator achieved superior diagnostic accuracy while reducing investigative costs.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday